| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 14 | +0.00% | +0.78% | +3.83% | -3.06% | -2.91% | — |
| 14d | 14 | +35.71% | -1.84% | +7.19% | -9.03% | -6.59% | — |
| 30d | 14 | +100.00% | -7.54% | +10.41% | -17.95% | -17.02% | — |
| 60d | 14(14 pending) | — | — | — | — | — | — |
| 90d | 14(14 pending) | — | — | — | — | — | — |
| 180d | 14(14 pending) | — | — | — | — | — | — |
| 1y | 14(14 pending) | — | — | — | — | — | — |
| 2y | 14(14 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED |
|---|---|---|---|---|---|---|---|
| ALNY ALNYLAM PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 199 | $333.94 | $66.5K | 9,443 | Apr 6, 2026 | Apr 7, 2026 ↗ |
| ALNY ALNYLAM PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 293 | $331.89 | $97.2K | 9,642 | Apr 6, 2026 | Apr 7, 2026 ↗ |
| ALNY ALNYLAM PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 909 | $329.76 | $299.8K | 10,764 | Apr 6, 2026 | Apr 7, 2026 ↗ |
| ALNY ALNYLAM PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 56 | $320.14 | $17.9K | 11,673 | Apr 6, 2026 | Apr 7, 2026 ↗ |
| ALNY ALNYLAM PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 829 | $330.46 | $274.0K | 9,935 | Apr 6, 2026 | Apr 7, 2026 ↗ |
| ALNY ALNYLAM PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 147 | $320.62 | $47.1K | 12,287 | Apr 2, 2026 | Apr 7, 2026 ↗ |
| ALNY ALNYLAM PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 86 | $319.69 | $27.5K | 12,434 | Apr 2, 2026 | Apr 7, 2026 ↗ |
| ALNY ALNYLAM PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 359 | $317.44 | $114.0K | 12,729 | Apr 2, 2026 | Apr 7, 2026 ↗ |
| ALNY ALNYLAM PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 209 | $318.47 | $66.6K | 12,520 | Apr 2, 2026 | Apr 7, 2026 ↗ |
| ALNY ALNYLAM PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 81 | $323.64 | $26.2K | 11,737 | Apr 2, 2026 | Apr 7, 2026 ↗ |
| ALNY ALNYLAM PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 265 | $316.61 | $83.9K | 13,088 | Apr 2, 2026 | Apr 7, 2026 ↗ |
| ALNY ALNYLAM PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 245 | $322.86 | $79.1K | 11,818 | Apr 2, 2026 | Apr 7, 2026 ↗ |
| ALNY ALNYLAM PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 8 | $325.49 | $2.6K | 11,729 | Apr 2, 2026 | Apr 7, 2026 ↗ |
| ALNY ALNYLAM PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 224 | $321.64 | $72.0K | 12,063 | Apr 2, 2026 | Apr 7, 2026 ↗ |